scholarly article | Q13442814 |
P50 | author | Gerhard Rogler | Q64750687 |
P2093 | author name string | Gerd Schmitz | |
Gerhard Liebisch | |||
Jurgen Bock | |||
Joachim Schweimer | |||
P2860 | cites work | Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis | Q24685584 |
Functional rafts in cell membranes | Q27860768 | ||
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy | Q28140319 | ||
Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease | Q28278595 | ||
Structure and function of sphingolipid- and cholesterol-rich membrane rafts | Q29618518 | ||
Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice | Q30881683 | ||
Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide | Q33807705 | ||
Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis | Q33909112 | ||
Intestinal permeability, leaky gut, and intestinal disorders | Q34027859 | ||
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability | Q34561438 | ||
Raft ceramide in molecular medicine | Q35559152 | ||
Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry | Q36040256 | ||
Cytokines and growth factor modulators in intestinal inflammation and repair | Q36043676 | ||
The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene | Q38335637 | ||
Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms | Q40423823 | ||
Depletion of Caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight-junction proteins | Q40500818 | ||
Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms | Q40614064 | ||
The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis | Q40649042 | ||
Inhibitors of glycosphingolipid biosynthesis reduce transepithelial electrical resistance in MDCK I and FRT cells | Q40682472 | ||
Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae | Q40863681 | ||
Tight junctions are membrane microdomains | Q40886204 | ||
Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation | Q41700006 | ||
Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. | Q42555356 | ||
Membrane restructuring via ceramide results in enhanced solute efflux | Q43858126 | ||
High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. | Q44225943 | ||
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts | Q44300453 | ||
Effect of gamma-linolenic acid or docosahexaenoic acid on tight junction permeability in intestinal monolayer cells and their mechanism by protein kinase C activation and/or eicosanoid formation | Q44319330 | ||
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells | Q44539962 | ||
Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function | Q44709173 | ||
PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. | Q44712899 | ||
High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm | Q45136777 | ||
High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. | Q48970037 | ||
Ceramide enables fas to cap and kill. | Q52542714 | ||
Polyunsaturated fatty acids reduce non-receptor-mediated transcellular permeation of protein across a model of intestinal epithelium in vitro. | Q54042664 | ||
Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. | Q54446964 | ||
Observation of Topical Catalysis by Sphingomyelinase Coupled To Microspheres | Q57365739 | ||
CD95 Signaling via Ceramide-rich Membrane Rafts | Q57371964 | ||
Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS) | Q61863054 | ||
TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown | Q67505708 | ||
Different effects of enzyme-generated ceramides and diacylglycerols in phospholipid membrane fusion and leakage | Q71742617 | ||
Tumor response to radiotherapy regulated by endothelial cell apoptosis | Q73401346 | ||
Ceramide-rich membrane rafts mediate CD40 clustering | Q77373931 | ||
Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane | Q77710438 | ||
P433 | issue | 39 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5217-5225 | |
P577 | publication date | 2007-10-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function | |
P478 | volume | 13 |
Q47157018 | Ablation of ceramide synthase 2 exacerbates dextran sodium sulphate-induced colitis in mice due to increased intestinal permeability. |
Q39768734 | Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells |
Q21131205 | Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics |
Q34874519 | Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model |
Q26765948 | Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces |
Q91639020 | Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis |
Q43614631 | Intestinal barrier function is modulated by short-term exposure to fumonisin B₁ in Ussing chambers |
Q33507287 | Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression |
Q42971462 | Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract. |
Q37980790 | Perspectives on immunomodulation early in life. |
Q37852814 | Physiological functions and clinical implications of sphingolipids in the gut. |
Q91810355 | Role of Ceramidases in Sphingolipid Metabolism and Human Diseases |
Q50130199 | Sphingolipid de novo biosynthesis is essential for intestine cell survival and barrier function. |
Q28073700 | Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease |
Q40104108 | The Role of Sphingolipids on Innate Immunity to Intestinal Salmonella Infection. |
Q54314252 | Ursolic acid inhibits acid sphingomyelinase in intestinal cells. |
Search more.